Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Clinical Lung Cancer|March 20, 2025
Completion Rates for Patients Undergoing Concurrent Chemoradiotherapy for Stage III Nonsmall Cell Lung Cancer and its Importance in the Era of Consolidation Immunotherapy: A Cohort StudyNeil D Wallace, Jing Xie, Marliese Alexander, et al.
Lung Cancer (Amsterdam, Netherlands)|February 23, 2020
A multicenter study of thromboembolic events among patients diagnosed with ROS1-rearranged non-small cell lung cancerMarliese Alexander, Nick Pavlakis, Thomas John, et al.
Oncogene|June 15, 2020
Targeting platelets for improved outcome in KRAS-driven lung adenocarcinomaStephanie R Hyslop, Marliese Alexander, Alesha A Thai, et al.
JAMA Oncology|September 21, 2023
Risk-Directed Ambulatory Thromboprophylaxis in Lung and Gastrointestinal Cancers: The TARGET-TP Randomized Clinical TrialMarliese Alexander, Sam Harris, Craig Underhill, et al.
Genetics in Medicine Open|October 27, 2025
Pharmacogenomics in pediatric oncology: Australian adolescent or young adult and caregiver perspectivesClaire Moore, Emma F Magavern, Marliese Alexander, et al.
Clinical and Translational Science|November 29, 2024
Pharmacogenetic-guided dosing for fluoropyrimidine (DPYD) and irinotecan (UGT1A1*28) chemotherapies for patients with cancer (PACIFIC-PGx): A multicenter clinical trialSarah Glewis, Senthil Lingaratnam, Benjamin Lee, et al.
Contemporary Clinical Trials|August 12, 2022
The Sleep, Cancer and Rest (SleepCaRe) Trial: Rationale and design of a randomized, controlled trial of cognitive behavioral and bright light therapy for insomnia and fatigue in women with breast cancer receiving chemotherapyJordan Maccora, Sheila N Garland, Maria Ftanou, et al.
Psycho-Oncology|March 22, 2026
A Randomized Controlled Trial: Evaluating the Sleep, Cancer and Rest (SleepCaRe) Trial to Improve Health-Related Quality of Life in Women Undergoing Chemotherapy for Breast CancerRebecca Wallace, Marliese Alexander, Daphne Day, et al.
Clinical Lung Cancer|August 27, 2022
A Multi-Center Real-World Experience of IMpower150 in Oncogene Driven Tumors and CNS MetastasesMalinda Itchins, Hannah Ainsworth, Marliese Alexander, et al.
Lung Cancer (Amsterdam, Netherlands)|December 10, 2025
Impact of PD-L1 on first-line osimertinib outcomes in EGFR-mutant NSCLC: real-world data from the AURORA25 study and meta-analysisMarliese Alexander, Malinda Itchins, Jonathan Felthun, et al.
Pageof 8